Cancer cells predominantly evade the immune system in two ways – they prevent immune cells from detecting them and they deactivate immune responses prematurely.Rather than directly augmenting immune responses, modern immunotherapies seek to inhibit or circumvent cancer cell immune evasion mechanisms.Heterogeneity within tumor cell and immune cell populations exists at the genetic, epigenetic and phenotypic level, and is a limiting factor for the efficacy of targeted therapeutic approaches.
Download this eBook to discover an antibody multiplexing technique that:
Allows for the detection and examination of multiple protein markers
Prevents cross-reactivity and signal spectral overlap complications
Requires shorter incubation times while consuming smaller antibody/probe volumes
Provides the speed and depth of information required for diagnostic purposes
